Motif ID: Taf1
Z-value: 2.847

Transcription factors associated with Taf1:
Gene Symbol | Entrez ID | Gene Name |
---|---|---|
Taf1 | ENSMUSG00000031314.11 | Taf1 |
Activity-expression correlation:
Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Taf1 | mm10_v2_chrX_+_101532734_101532777 | 0.77 | 3.6e-09 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.6 | 17.9 | GO:1904908 | negative regulation of maintenance of sister chromatid cohesion(GO:0034092) negative regulation of maintenance of mitotic sister chromatid cohesion(GO:0034183) maintenance of mitotic sister chromatid cohesion, telomeric(GO:0099403) mitotic sister chromatid cohesion, telomeric(GO:0099404) regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904907) negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904908) |
3.5 | 10.4 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
3.4 | 10.2 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
2.8 | 8.3 | GO:0019046 | release from viral latency(GO:0019046) |
2.4 | 9.4 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
2.4 | 11.8 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
2.2 | 8.9 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
2.0 | 5.9 | GO:1902528 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
1.9 | 7.7 | GO:0072362 | regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072362) |
1.8 | 1.8 | GO:0060489 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
1.8 | 7.2 | GO:0070829 | heterochromatin maintenance(GO:0070829) |
1.8 | 5.4 | GO:0019858 | cytosine metabolic process(GO:0019858) |
1.8 | 7.1 | GO:0086048 | membrane depolarization during bundle of His cell action potential(GO:0086048) |
1.6 | 6.6 | GO:0097494 | regulation of vesicle size(GO:0097494) |
1.6 | 4.9 | GO:0070650 | actin filament bundle distribution(GO:0070650) |
1.5 | 1.5 | GO:0035844 | cloaca development(GO:0035844) |
1.5 | 4.5 | GO:1901608 | dense core granule localization(GO:0032253) cellular response to isoquinoline alkaloid(GO:0071317) regulation of vesicle transport along microtubule(GO:1901608) dense core granule transport(GO:1901950) regulation of dense core granule transport(GO:1904809) positive regulation of dense core granule transport(GO:1904811) |
1.5 | 4.4 | GO:0016598 | protein arginylation(GO:0016598) |
1.4 | 4.3 | GO:1900275 | negative regulation of phospholipase C activity(GO:1900275) |
1.4 | 10.0 | GO:0071699 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
1.4 | 7.1 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
1.4 | 4.2 | GO:0043323 | positive regulation of natural killer cell degranulation(GO:0043323) |
1.3 | 3.9 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
1.3 | 5.0 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
1.3 | 7.5 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
1.2 | 7.4 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) establishment of Sertoli cell barrier(GO:0097368) |
1.2 | 2.4 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
1.2 | 3.5 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
1.2 | 4.6 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
1.1 | 3.4 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
1.1 | 11.1 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
1.1 | 5.4 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
1.0 | 3.1 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
1.0 | 4.9 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) |
1.0 | 2.9 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
1.0 | 4.9 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
1.0 | 7.6 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.9 | 1.8 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.9 | 2.8 | GO:0043379 | memory T cell differentiation(GO:0043379) response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
0.9 | 0.9 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.9 | 2.7 | GO:0035574 | histone H4-K20 demethylation(GO:0035574) |
0.9 | 8.9 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.9 | 2.7 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) |
0.9 | 7.1 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
0.9 | 3.5 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.9 | 5.2 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.9 | 3.4 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
0.9 | 4.3 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
0.8 | 5.0 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
0.8 | 5.8 | GO:0030242 | pexophagy(GO:0030242) |
0.8 | 4.9 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.8 | 3.3 | GO:2001045 | closure of optic fissure(GO:0061386) negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.8 | 2.5 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.8 | 2.4 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.8 | 3.2 | GO:0032910 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
0.8 | 4.8 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.8 | 11.2 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.8 | 5.5 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.8 | 2.3 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
0.8 | 2.3 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
0.7 | 3.0 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.7 | 3.6 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.7 | 2.2 | GO:0090004 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.7 | 2.1 | GO:0048611 | ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
0.7 | 10.6 | GO:0045974 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.7 | 3.5 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.7 | 9.8 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.7 | 11.6 | GO:0090169 | regulation of spindle assembly(GO:0090169) |
0.7 | 2.7 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.7 | 2.0 | GO:0098928 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
0.7 | 2.0 | GO:1901079 | positive regulation of relaxation of muscle(GO:1901079) |
0.7 | 2.6 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.6 | 3.9 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.6 | 7.1 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.6 | 1.9 | GO:0019085 | early viral transcription(GO:0019085) |
0.6 | 1.9 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
0.6 | 3.7 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.6 | 1.9 | GO:0072720 | response to sorbitol(GO:0072708) response to dithiothreitol(GO:0072720) |
0.6 | 1.9 | GO:0099547 | regulation of translation at synapse, modulating synaptic transmission(GO:0099547) regulation of translation at postsynapse, modulating synaptic transmission(GO:0099578) positive regulation of intracellular transport of viral material(GO:1901254) |
0.6 | 1.8 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.6 | 6.7 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.6 | 2.4 | GO:0009414 | response to water deprivation(GO:0009414) |
0.6 | 1.8 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.6 | 2.9 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.6 | 1.7 | GO:1905077 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) negative regulation of interleukin-17 secretion(GO:1905077) |
0.6 | 5.2 | GO:0043631 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
0.6 | 2.8 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.6 | 4.5 | GO:0048102 | autophagic cell death(GO:0048102) |
0.6 | 1.1 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.6 | 1.7 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.5 | 1.6 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.5 | 2.2 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.5 | 1.1 | GO:0060853 | arterial endothelial cell fate commitment(GO:0060844) blood vessel endothelial cell fate commitment(GO:0060846) endothelial cell fate specification(GO:0060847) Notch signaling pathway involved in arterial endothelial cell fate commitment(GO:0060853) blood vessel endothelial cell fate specification(GO:0097101) |
0.5 | 1.6 | GO:0048209 | regulation of vesicle targeting, to, from or within Golgi(GO:0048209) |
0.5 | 4.3 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.5 | 4.3 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.5 | 2.6 | GO:0060295 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.5 | 1.0 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.5 | 2.5 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
0.5 | 4.0 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.5 | 2.0 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.5 | 9.0 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.5 | 1.5 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) protein K29-linked ubiquitination(GO:0035519) |
0.5 | 1.5 | GO:0007128 | meiotic prophase I(GO:0007128) prophase(GO:0051324) |
0.5 | 2.5 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.5 | 1.0 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.5 | 2.9 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.5 | 2.4 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.5 | 0.9 | GO:2000273 | positive regulation of receptor activity(GO:2000273) |
0.5 | 4.1 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.5 | 5.9 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.5 | 1.8 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.4 | 1.3 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
0.4 | 5.3 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.4 | 3.1 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.4 | 1.8 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
0.4 | 1.7 | GO:0045358 | negative regulation of interferon-beta biosynthetic process(GO:0045358) |
0.4 | 0.9 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.4 | 8.3 | GO:0042119 | neutrophil activation(GO:0042119) |
0.4 | 10.0 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.4 | 1.7 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.4 | 3.0 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
0.4 | 2.9 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.4 | 2.0 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.4 | 3.2 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.4 | 1.6 | GO:1903760 | regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903760) regulation of potassium ion export across plasma membrane(GO:1903764) regulation of membrane repolarization during ventricular cardiac muscle cell action potential(GO:1905024) |
0.4 | 1.2 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.4 | 2.4 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
0.4 | 4.3 | GO:0010650 | positive regulation of cell communication by electrical coupling(GO:0010650) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
0.4 | 0.8 | GO:1905051 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
0.4 | 1.2 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.4 | 1.2 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.4 | 2.3 | GO:0098964 | dendritic transport of ribonucleoprotein complex(GO:0098961) dendritic transport of messenger ribonucleoprotein complex(GO:0098963) anterograde dendritic transport of messenger ribonucleoprotein complex(GO:0098964) |
0.4 | 1.2 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.4 | 3.8 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.4 | 3.8 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.4 | 1.5 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) positive regulation of isotype switching to IgA isotypes(GO:0048298) |
0.4 | 1.5 | GO:0090237 | positive regulation of sphingolipid biosynthetic process(GO:0090154) regulation of arachidonic acid secretion(GO:0090237) positive regulation of arachidonic acid secretion(GO:0090238) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.4 | 1.5 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.4 | 2.9 | GO:0015074 | DNA integration(GO:0015074) |
0.4 | 2.2 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.4 | 3.6 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) |
0.4 | 1.8 | GO:0010636 | positive regulation of mitochondrial fusion(GO:0010636) |
0.4 | 0.7 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.4 | 1.4 | GO:0071105 | response to interleukin-11(GO:0071105) |
0.4 | 1.4 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
0.4 | 1.1 | GO:0098937 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
0.4 | 4.6 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.4 | 1.1 | GO:0060729 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) intestinal epithelial structure maintenance(GO:0060729) |
0.4 | 2.1 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.4 | 1.8 | GO:0034088 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.4 | 3.2 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.4 | 2.1 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.4 | 1.4 | GO:0035937 | estrogen secretion(GO:0035937) estradiol secretion(GO:0035938) regulation of estrogen secretion(GO:2000861) regulation of estradiol secretion(GO:2000864) |
0.4 | 1.4 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.3 | 1.0 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.3 | 1.0 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.3 | 11.0 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.3 | 8.9 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.3 | 2.7 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.3 | 1.0 | GO:2000616 | negative regulation of histone H3-K9 acetylation(GO:2000616) |
0.3 | 2.1 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.3 | 1.7 | GO:0070417 | cellular response to cold(GO:0070417) |
0.3 | 0.3 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.3 | 3.3 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.3 | 1.3 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.3 | 2.3 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.3 | 2.6 | GO:0048570 | notochord morphogenesis(GO:0048570) |
0.3 | 2.6 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.3 | 3.2 | GO:1900086 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.3 | 6.4 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.3 | 0.6 | GO:0019062 | virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) |
0.3 | 1.3 | GO:0006751 | glutathione catabolic process(GO:0006751) |
0.3 | 0.3 | GO:0060702 | negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) |
0.3 | 0.9 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
0.3 | 1.8 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.3 | 1.5 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.3 | 0.9 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.3 | 2.4 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.3 | 2.7 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.3 | 1.2 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.3 | 1.4 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.3 | 8.8 | GO:0007520 | myoblast fusion(GO:0007520) |
0.3 | 1.7 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.3 | 0.6 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.3 | 1.1 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.3 | 0.8 | GO:0031590 | wybutosine metabolic process(GO:0031590) wybutosine biosynthetic process(GO:0031591) |
0.3 | 1.9 | GO:0035735 | microtubule anchoring at centrosome(GO:0034454) intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.3 | 0.8 | GO:0070197 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.3 | 1.1 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.3 | 3.0 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.3 | 0.3 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.3 | 1.6 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.3 | 1.9 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.3 | 3.2 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.3 | 7.2 | GO:0010955 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.3 | 1.6 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
0.3 | 0.8 | GO:0019389 | glucuronoside metabolic process(GO:0019389) |
0.3 | 2.4 | GO:0036371 | protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
0.3 | 0.5 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.3 | 0.8 | GO:0070625 | zymogen granule exocytosis(GO:0070625) |
0.3 | 1.6 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.3 | 9.2 | GO:0021522 | spinal cord motor neuron differentiation(GO:0021522) |
0.3 | 1.8 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.3 | 0.8 | GO:0060821 | inactivation of X chromosome by DNA methylation(GO:0060821) |
0.3 | 1.6 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.3 | 0.8 | GO:0002447 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil activation(GO:0043307) eosinophil degranulation(GO:0043308) |
0.3 | 1.0 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.3 | 1.8 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.3 | 0.5 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) |
0.3 | 1.8 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.2 | 3.7 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.2 | 2.2 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.2 | 1.5 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.2 | 3.4 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.2 | 1.2 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.2 | 1.0 | GO:0021502 | columnar/cuboidal epithelial cell maturation(GO:0002069) neural fold elevation formation(GO:0021502) epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.2 | 1.9 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.2 | 0.7 | GO:0097401 | synaptic vesicle lumen acidification(GO:0097401) |
0.2 | 1.7 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.2 | 0.7 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
0.2 | 1.6 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.2 | 1.4 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.2 | 3.2 | GO:2000780 | negative regulation of double-strand break repair(GO:2000780) |
0.2 | 1.8 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.2 | 3.6 | GO:0034389 | lipid particle organization(GO:0034389) |
0.2 | 3.1 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.2 | 4.0 | GO:0021684 | cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.2 | 1.1 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.2 | 0.2 | GO:0034382 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.2 | 1.7 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.2 | 1.5 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.2 | 1.5 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.2 | 9.1 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.2 | 1.7 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.2 | 1.0 | GO:0014029 | neural crest formation(GO:0014029) |
0.2 | 1.2 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.2 | 0.6 | GO:1903538 | meiotic sister chromatid cohesion, centromeric(GO:0051754) meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
0.2 | 0.6 | GO:0048254 | snoRNA localization(GO:0048254) |
0.2 | 6.5 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.2 | 2.6 | GO:1990403 | embryonic brain development(GO:1990403) |
0.2 | 1.1 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
0.2 | 1.7 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.2 | 0.7 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
0.2 | 1.3 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.2 | 2.2 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.2 | 4.4 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.2 | 1.7 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.2 | 1.6 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.2 | 2.2 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.2 | 3.4 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.2 | 1.6 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.2 | 1.8 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.2 | 0.7 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.2 | 1.7 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.2 | 0.5 | GO:0046958 | nonassociative learning(GO:0046958) |
0.2 | 6.3 | GO:0019228 | neuronal action potential(GO:0019228) |
0.2 | 0.5 | GO:0072382 | minus-end-directed vesicle transport along microtubule(GO:0072382) |
0.2 | 3.0 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
0.2 | 5.2 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.2 | 0.7 | GO:0032429 | regulation of phospholipase A2 activity(GO:0032429) |
0.2 | 1.3 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.2 | 2.1 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.2 | 0.7 | GO:0000423 | macromitophagy(GO:0000423) response to mitochondrial depolarisation(GO:0098780) |
0.2 | 2.8 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.2 | 3.1 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.2 | 0.6 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.2 | 2.6 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.2 | 0.5 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.2 | 1.4 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.2 | 5.0 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.2 | 2.5 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.2 | 1.7 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
0.2 | 0.8 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.1 | 0.7 | GO:0006868 | glutamine transport(GO:0006868) |
0.1 | 1.0 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.1 | 1.6 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.1 | 1.5 | GO:0016246 | RNA interference(GO:0016246) |
0.1 | 0.7 | GO:0002121 | inter-male aggressive behavior(GO:0002121) response to pheromone(GO:0019236) |
0.1 | 2.0 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.1 | 1.0 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.1 | 1.7 | GO:2000641 | regulation of early endosome to late endosome transport(GO:2000641) |
0.1 | 6.4 | GO:0008542 | visual learning(GO:0008542) |
0.1 | 0.4 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.1 | 0.7 | GO:0060561 | apoptotic process involved in morphogenesis(GO:0060561) |
0.1 | 0.4 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.1 | 2.1 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.1 | 0.5 | GO:1903859 | regulation of dendrite extension(GO:1903859) |
0.1 | 1.3 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.1 | 1.2 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.1 | 0.7 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.1 | 0.8 | GO:0060008 | Sertoli cell differentiation(GO:0060008) |
0.1 | 0.7 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.1 | 1.3 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 1.3 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.1 | 1.4 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.1 | 1.4 | GO:0033572 | transferrin transport(GO:0033572) |
0.1 | 1.7 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
0.1 | 1.3 | GO:0060307 | regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) |
0.1 | 0.6 | GO:0045176 | apical protein localization(GO:0045176) |
0.1 | 2.5 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.1 | 4.7 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.1 | 1.6 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.1 | 1.5 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.1 | 4.7 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.1 | 1.9 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
0.1 | 0.8 | GO:0032380 | dolichol metabolic process(GO:0019348) regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.1 | 1.4 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.1 | 0.8 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.1 | 0.5 | GO:1903912 | regulation of translation in response to endoplasmic reticulum stress(GO:0036490) regulation of translation initiation in response to endoplasmic reticulum stress(GO:0036491) eiF2alpha phosphorylation in response to endoplasmic reticulum stress(GO:0036492) negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.1 | 2.1 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.1 | 3.3 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.1 | 0.9 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.1 | 1.9 | GO:0046886 | positive regulation of hormone biosynthetic process(GO:0046886) |
0.1 | 3.7 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.1 | 0.9 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 0.6 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
0.1 | 0.5 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.1 | 1.3 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.1 | 1.0 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.1 | 2.8 | GO:0032355 | response to estradiol(GO:0032355) |
0.1 | 0.9 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.1 | 0.7 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
0.1 | 0.3 | GO:0061734 | parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
0.1 | 0.8 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.1 | 3.7 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.1 | 0.6 | GO:0032811 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) negative regulation of epinephrine secretion(GO:0032811) |
0.1 | 1.6 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 1.5 | GO:0060746 | parental behavior(GO:0060746) |
0.1 | 1.0 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 1.8 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.1 | 6.1 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.1 | 0.9 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.7 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.1 | 1.2 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 0.4 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.1 | 0.7 | GO:2000637 | positive regulation of posttranscriptional gene silencing(GO:0060148) positive regulation of gene silencing by miRNA(GO:2000637) |
0.1 | 0.6 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.1 | 0.4 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.1 | 0.6 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 0.7 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
0.1 | 10.8 | GO:1990830 | response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
0.1 | 2.1 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.1 | 0.6 | GO:0071380 | cellular response to prostaglandin stimulus(GO:0071379) cellular response to prostaglandin E stimulus(GO:0071380) |
0.1 | 1.5 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.1 | 1.1 | GO:0051642 | centrosome localization(GO:0051642) |
0.1 | 3.1 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 2.2 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.1 | 0.7 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 0.8 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.1 | 3.2 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.1 | 6.6 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.1 | 2.5 | GO:0003170 | heart valve development(GO:0003170) |
0.1 | 0.4 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.1 | 2.4 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
0.1 | 1.2 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.1 | 2.3 | GO:0017145 | stem cell division(GO:0017145) |
0.1 | 1.2 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.1 | 1.9 | GO:0031663 | lipopolysaccharide-mediated signaling pathway(GO:0031663) |
0.1 | 7.2 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.1 | 0.9 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) |
0.1 | 2.5 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
0.1 | 0.6 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of cell junction assembly(GO:1901889) negative regulation of adherens junction organization(GO:1903392) |
0.1 | 1.6 | GO:0090102 | cochlea development(GO:0090102) |
0.1 | 1.7 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
0.1 | 0.8 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.1 | 0.2 | GO:0015882 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
0.1 | 0.5 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 0.5 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.1 | 1.4 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 0.7 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.1 | 1.8 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.1 | 0.2 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 1.1 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.3 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.1 | 0.4 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.1 | 0.5 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.1 | 0.4 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.1 | 0.1 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
0.1 | 0.2 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.1 | 0.3 | GO:0060412 | ventricular septum morphogenesis(GO:0060412) |
0.1 | 0.4 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.1 | 1.2 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.1 | 0.5 | GO:0080009 | mRNA methylation(GO:0080009) |
0.1 | 3.6 | GO:0007631 | feeding behavior(GO:0007631) |
0.1 | 0.3 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
0.0 | 0.1 | GO:0009838 | abscission(GO:0009838) |
0.0 | 0.9 | GO:0007097 | nuclear migration(GO:0007097) establishment of nucleus localization(GO:0040023) |
0.0 | 0.3 | GO:0035459 | cargo loading into vesicle(GO:0035459) cargo loading into COPII-coated vesicle(GO:0090110) |
0.0 | 0.3 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.0 | 1.1 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.0 | 0.2 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.0 | 0.6 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.0 | 1.7 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.0 | 3.0 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.4 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.0 | 0.4 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.0 | 0.4 | GO:0051255 | spindle midzone assembly(GO:0051255) mitotic spindle midzone assembly(GO:0051256) |
0.0 | 0.7 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.0 | 0.1 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.0 | 0.5 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.0 | 0.2 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.0 | 0.3 | GO:0032366 | intracellular lipid transport(GO:0032365) intracellular sterol transport(GO:0032366) intracellular cholesterol transport(GO:0032367) |
0.0 | 0.1 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
0.0 | 1.0 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.0 | 0.4 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.0 | 0.1 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.0 | 0.4 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.0 | 1.1 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.0 | 1.1 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.0 | 0.1 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.0 | 0.3 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
0.0 | 0.1 | GO:0051013 | microtubule severing(GO:0051013) |
0.0 | 1.3 | GO:0008543 | fibroblast growth factor receptor signaling pathway(GO:0008543) |
0.0 | 0.2 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.0 | 0.3 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.0 | 0.4 | GO:1902003 | regulation of beta-amyloid formation(GO:1902003) |
0.0 | 2.2 | GO:0030509 | BMP signaling pathway(GO:0030509) |
0.0 | 0.7 | GO:0007173 | epidermal growth factor receptor signaling pathway(GO:0007173) |
0.0 | 0.5 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.0 | 0.2 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.0 | 0.7 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.0 | 0.5 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.0 | 0.3 | GO:0034204 | lipid translocation(GO:0034204) |
0.0 | 0.5 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.0 | 2.3 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
0.0 | 0.2 | GO:0009649 | entrainment of circadian clock(GO:0009649) entrainment of circadian clock by photoperiod(GO:0043153) |
0.0 | 3.5 | GO:0018108 | peptidyl-tyrosine phosphorylation(GO:0018108) |
0.0 | 0.5 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.0 | 0.3 | GO:0043967 | histone H4 acetylation(GO:0043967) |
0.0 | 0.2 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
0.0 | 1.0 | GO:0007281 | germ cell development(GO:0007281) |
0.0 | 1.3 | GO:0061025 | membrane fusion(GO:0061025) |
0.0 | 1.9 | GO:0007160 | cell-matrix adhesion(GO:0007160) |
0.0 | 0.0 | GO:0003161 | cardiac conduction system development(GO:0003161) atrioventricular node development(GO:0003162) |
0.0 | 0.2 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.0 | 0.4 | GO:0034394 | protein localization to cell surface(GO:0034394) |
0.0 | 0.1 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.0 | 0.5 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.0 | 0.3 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.0 | 0.4 | GO:0097006 | regulation of plasma lipoprotein particle levels(GO:0097006) |
0.0 | 0.3 | GO:0006767 | water-soluble vitamin metabolic process(GO:0006767) |
0.0 | 0.4 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.0 | 1.3 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.0 | 0.1 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.0 | 0.1 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
0.0 | 0.1 | GO:0014047 | glutamate secretion(GO:0014047) |
0.0 | 0.5 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.0 | 1.5 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.0 | 0.2 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.0 | 0.1 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.0 | 0.0 | GO:0051182 | coenzyme transport(GO:0051182) |
0.0 | 1.3 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
0.0 | 0.5 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.0 | 1.0 | GO:0009952 | anterior/posterior pattern specification(GO:0009952) |
0.0 | 0.1 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) paranodal junction assembly(GO:0030913) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.0 | 0.1 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
0.0 | 1.2 | GO:0006814 | sodium ion transport(GO:0006814) |
0.0 | 0.5 | GO:0021549 | cerebellum development(GO:0021549) |
0.0 | 0.2 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
Gene overrepresentation in cellular_component category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.5 | 13.9 | GO:1990421 | subtelomeric heterochromatin(GO:1990421) nuclear subtelomeric heterochromatin(GO:1990707) |
2.2 | 8.6 | GO:0044307 | dendritic branch(GO:0044307) |
1.2 | 9.8 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
1.2 | 9.7 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
1.2 | 1.2 | GO:0098830 | presynaptic endosome(GO:0098830) |
1.1 | 11.5 | GO:0000805 | X chromosome(GO:0000805) |
1.1 | 7.6 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
1.0 | 1.0 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) clathrin-coated endocytic vesicle membrane(GO:0030669) |
1.0 | 7.8 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.9 | 2.8 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.9 | 6.3 | GO:0071203 | WASH complex(GO:0071203) |
0.9 | 2.6 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.9 | 3.4 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.8 | 4.9 | GO:0097513 | myosin II filament(GO:0097513) |
0.7 | 3.6 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.7 | 3.6 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.7 | 7.1 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.7 | 9.0 | GO:1990635 | proximal dendrite(GO:1990635) |
0.7 | 6.2 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.7 | 3.4 | GO:0098831 | presynaptic active zone cytoplasmic component(GO:0098831) |
0.7 | 2.0 | GO:0036125 | mitochondrial fatty acid beta-oxidation multienzyme complex(GO:0016507) fatty acid beta-oxidation multienzyme complex(GO:0036125) |
0.7 | 6.1 | GO:0097227 | sperm annulus(GO:0097227) |
0.7 | 6.1 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.6 | 5.3 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.6 | 11.8 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.6 | 1.7 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
0.5 | 2.1 | GO:1990590 | ATF1-ATF4 transcription factor complex(GO:1990590) |
0.5 | 1.6 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.5 | 3.7 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.5 | 1.5 | GO:0098835 | presynaptic endocytic zone(GO:0098833) presynaptic endocytic zone membrane(GO:0098835) |
0.5 | 2.5 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.5 | 2.0 | GO:0031673 | H zone(GO:0031673) |
0.5 | 2.0 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.5 | 1.9 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.5 | 4.6 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.5 | 8.1 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.4 | 9.8 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.4 | 1.8 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.4 | 2.6 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
0.4 | 4.7 | GO:0032584 | growth cone membrane(GO:0032584) |
0.4 | 1.7 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.4 | 5.5 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.4 | 2.9 | GO:0001940 | male pronucleus(GO:0001940) |
0.4 | 2.1 | GO:1990745 | EARP complex(GO:1990745) |
0.4 | 9.5 | GO:0000242 | pericentriolar material(GO:0000242) |
0.4 | 4.0 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.4 | 2.4 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.4 | 1.4 | GO:0032426 | stereocilium tip(GO:0032426) |
0.3 | 3.0 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.3 | 6.7 | GO:0016580 | Sin3 complex(GO:0016580) |
0.3 | 8.5 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.3 | 5.9 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.3 | 3.5 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.3 | 1.0 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.3 | 5.7 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.3 | 8.6 | GO:0033268 | node of Ranvier(GO:0033268) |
0.3 | 3.4 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.3 | 6.3 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.3 | 2.4 | GO:0000812 | Swr1 complex(GO:0000812) |
0.3 | 2.3 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.3 | 2.5 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.3 | 1.8 | GO:0033263 | CORVET complex(GO:0033263) |
0.2 | 2.0 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.2 | 2.2 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.2 | 7.4 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.2 | 1.2 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.2 | 1.5 | GO:0005955 | calcineurin complex(GO:0005955) |
0.2 | 0.2 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.2 | 1.2 | GO:0072487 | MSL complex(GO:0072487) |
0.2 | 4.5 | GO:0031252 | cell leading edge(GO:0031252) |
0.2 | 0.7 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.2 | 4.2 | GO:0035102 | PRC1 complex(GO:0035102) |
0.2 | 0.9 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.2 | 2.5 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.2 | 3.4 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.2 | 1.1 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.2 | 7.6 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.2 | 4.2 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.2 | 2.1 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.2 | 0.6 | GO:0001939 | female pronucleus(GO:0001939) |
0.2 | 1.0 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.2 | 1.7 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.2 | 1.1 | GO:0070695 | FHF complex(GO:0070695) |
0.2 | 1.1 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.2 | 1.5 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.2 | 8.6 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.2 | 3.5 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.2 | 2.8 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.2 | 11.0 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.2 | 0.9 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.2 | 12.5 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.2 | 2.4 | GO:0000145 | exocyst(GO:0000145) |
0.2 | 1.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.2 | 2.2 | GO:0005686 | U2 snRNP(GO:0005686) |
0.2 | 1.5 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.2 | 1.0 | GO:0010369 | chromocenter(GO:0010369) |
0.2 | 1.1 | GO:0002177 | manchette(GO:0002177) |
0.2 | 1.8 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.2 | 0.5 | GO:0098842 | postsynaptic early endosome(GO:0098842) |
0.2 | 4.0 | GO:0071565 | nBAF complex(GO:0071565) |
0.2 | 1.4 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.1 | 0.9 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.1 | 1.1 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 2.2 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 1.9 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 3.3 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 0.9 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.1 | 0.5 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.1 | 2.1 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 4.7 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.1 | 0.8 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 11.9 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 0.5 | GO:0032280 | symmetric synapse(GO:0032280) |
0.1 | 9.0 | GO:0031526 | brush border membrane(GO:0031526) |
0.1 | 1.5 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 6.4 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.1 | 3.5 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.1 | 0.7 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 3.8 | GO:0035861 | site of double-strand break(GO:0035861) |
0.1 | 0.6 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
0.1 | 1.7 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 0.5 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.1 | 4.0 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.1 | 0.9 | GO:0031415 | NatA complex(GO:0031415) |
0.1 | 0.6 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 1.2 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.1 | 3.3 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.1 | 2.8 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.1 | 1.3 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 2.2 | GO:0060170 | ciliary membrane(GO:0060170) |
0.1 | 0.5 | GO:0036396 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
0.1 | 2.2 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 9.5 | GO:0036064 | ciliary basal body(GO:0036064) |
0.1 | 3.4 | GO:0043034 | costamere(GO:0043034) |
0.1 | 3.7 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 0.4 | GO:0005745 | m-AAA complex(GO:0005745) |
0.1 | 1.1 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.1 | 0.5 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.1 | 1.3 | GO:0051286 | cell tip(GO:0051286) |
0.1 | 0.7 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.1 | 0.6 | GO:0033503 | HULC complex(GO:0033503) |
0.1 | 0.9 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 0.6 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.1 | 2.4 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 0.9 | GO:0031011 | Ino80 complex(GO:0031011) |
0.1 | 1.7 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.1 | 13.2 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.1 | 5.0 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 5.9 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.1 | 13.3 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.1 | 5.8 | GO:0016605 | PML body(GO:0016605) |
0.1 | 11.6 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.1 | 2.3 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 1.6 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.1 | 2.1 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.1 | 1.8 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.1 | 3.8 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.1 | 0.6 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.1 | 7.5 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 5.9 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.1 | 0.9 | GO:0043656 | host intracellular part(GO:0033646) intracellular region of host(GO:0043656) |
0.1 | 0.9 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 0.9 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 1.9 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.1 | 0.7 | GO:0032590 | dendrite membrane(GO:0032590) |
0.1 | 0.2 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.1 | 0.5 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.1 | 0.8 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.1 | 7.3 | GO:0012506 | vesicle membrane(GO:0012506) |
0.1 | 9.6 | GO:0030426 | growth cone(GO:0030426) |
0.1 | 1.2 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 0.2 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.1 | 1.2 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.1 | 2.0 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 0.4 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.0 | 0.7 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 1.6 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.3 | GO:0070187 | telosome(GO:0070187) |
0.0 | 7.6 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 3.2 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 6.6 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.0 | 0.2 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.0 | 1.5 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 1.8 | GO:0030133 | transport vesicle(GO:0030133) |
0.0 | 0.4 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 1.0 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 0.5 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.0 | 1.9 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 1.1 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.2 | GO:0030478 | actin cap(GO:0030478) |
0.0 | 0.7 | GO:0031672 | A band(GO:0031672) |
0.0 | 3.4 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 10.4 | GO:0005768 | endosome(GO:0005768) |
0.0 | 0.2 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.5 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 2.8 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.0 | 0.1 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 1.9 | GO:0045177 | apical part of cell(GO:0045177) |
0.0 | 1.9 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.0 | 9.9 | GO:0031226 | intrinsic component of plasma membrane(GO:0031226) |
0.0 | 0.9 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.0 | 0.1 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.0 | 0.1 | GO:0090543 | Flemming body(GO:0090543) |
0.0 | 0.1 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 0.2 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.0 | 0.7 | GO:0005923 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.0 | 0.2 | GO:0005776 | autophagosome(GO:0005776) |
Gene overrepresentation in molecular_function category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.6 | 7.9 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
2.4 | 7.2 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
2.0 | 14.0 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
2.0 | 13.9 | GO:0015616 | DNA translocase activity(GO:0015616) |
1.7 | 10.2 | GO:0097001 | ceramide binding(GO:0097001) |
1.6 | 13.0 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
1.4 | 4.3 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
1.4 | 9.8 | GO:0099609 | microtubule lateral binding(GO:0099609) |
1.4 | 12.4 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
1.1 | 3.3 | GO:0035500 | MH2 domain binding(GO:0035500) |
1.1 | 3.2 | GO:0001156 | TFIIIC-class transcription factor binding(GO:0001156) |
1.0 | 3.9 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
1.0 | 7.7 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.9 | 5.6 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.9 | 2.7 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
0.9 | 7.1 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.9 | 3.5 | GO:0004092 | carnitine O-acetyltransferase activity(GO:0004092) |
0.9 | 3.5 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.8 | 4.9 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.8 | 4.8 | GO:0070728 | leucine binding(GO:0070728) |
0.8 | 3.2 | GO:0036033 | mediator complex binding(GO:0036033) |
0.8 | 4.7 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.8 | 3.1 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.8 | 2.3 | GO:0004658 | propionyl-CoA carboxylase activity(GO:0004658) |
0.8 | 2.3 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.8 | 5.4 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.7 | 2.1 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
0.7 | 2.1 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.7 | 14.6 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.7 | 7.2 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.7 | 3.3 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.6 | 12.2 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.6 | 1.9 | GO:0036361 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
0.6 | 3.7 | GO:0097016 | L27 domain binding(GO:0097016) |
0.6 | 3.6 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.6 | 2.3 | GO:0035473 | lipase binding(GO:0035473) |
0.6 | 3.4 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.6 | 9.4 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.6 | 7.2 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.5 | 1.6 | GO:0005119 | smoothened binding(GO:0005119) |
0.5 | 5.7 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.5 | 2.0 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.5 | 1.5 | GO:1990955 | G-rich single-stranded DNA binding(GO:1990955) |
0.5 | 3.1 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.5 | 1.5 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.5 | 1.5 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) single guanine insertion binding(GO:0032142) |
0.5 | 1.9 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.5 | 0.9 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.4 | 1.2 | GO:0046969 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
0.4 | 1.7 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.4 | 0.8 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.4 | 2.1 | GO:0050733 | RS domain binding(GO:0050733) |
0.4 | 1.6 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.4 | 9.8 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.4 | 9.9 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.4 | 1.5 | GO:2001069 | glycogen binding(GO:2001069) |
0.4 | 1.5 | GO:0005093 | Rab GDP-dissociation inhibitor activity(GO:0005093) |
0.4 | 2.9 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.4 | 2.5 | GO:0031419 | cobalamin binding(GO:0031419) |
0.4 | 1.4 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
0.3 | 1.0 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.3 | 5.5 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.3 | 2.1 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.3 | 4.4 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.3 | 1.7 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.3 | 2.6 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.3 | 4.3 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.3 | 4.9 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.3 | 1.9 | GO:0045545 | syndecan binding(GO:0045545) |
0.3 | 1.6 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.3 | 1.9 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.3 | 0.6 | GO:0002135 | CTP binding(GO:0002135) |
0.3 | 1.6 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.3 | 7.4 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.3 | 2.1 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.3 | 0.9 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.3 | 3.6 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.3 | 1.5 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.3 | 0.9 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.3 | 2.0 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.3 | 1.7 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.3 | 3.1 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.3 | 1.9 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.3 | 9.2 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.3 | 3.5 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.3 | 2.7 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.3 | 1.6 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
0.3 | 2.9 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.3 | 8.5 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.3 | 14.0 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.3 | 12.8 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.3 | 2.3 | GO:0039706 | co-receptor binding(GO:0039706) |
0.2 | 1.5 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.2 | 1.2 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.2 | 2.2 | GO:0071253 | connexin binding(GO:0071253) |
0.2 | 1.2 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.2 | 1.9 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.2 | 0.5 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.2 | 1.0 | GO:0043426 | MRF binding(GO:0043426) |
0.2 | 2.1 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.2 | 1.4 | GO:0033691 | sialic acid binding(GO:0033691) |
0.2 | 5.4 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.2 | 2.3 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.2 | 1.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 4.6 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.2 | 3.0 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.2 | 3.2 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.2 | 5.6 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.2 | 7.6 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.2 | 1.1 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.2 | 0.7 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.2 | 1.3 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.2 | 0.9 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.2 | 4.3 | GO:0031402 | sodium ion binding(GO:0031402) |
0.2 | 0.4 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.2 | 4.3 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.2 | 10.0 | GO:0035064 | methylated histone binding(GO:0035064) |
0.2 | 0.8 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
0.2 | 7.5 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.2 | 9.2 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.2 | 2.2 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.2 | 0.6 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.2 | 1.3 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.2 | 1.7 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.2 | 1.9 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) inositol trisphosphate phosphatase activity(GO:0046030) |
0.2 | 5.2 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.2 | 8.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.2 | 7.6 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.2 | 1.3 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.2 | 2.7 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.2 | 10.2 | GO:0017022 | myosin binding(GO:0017022) |
0.2 | 1.9 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.2 | 0.5 | GO:0000992 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) RNA polymerase III transcription factor activity, sequence-specific DNA binding(GO:0001034) |
0.2 | 4.6 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.2 | 1.3 | GO:0030911 | TPR domain binding(GO:0030911) |
0.2 | 3.3 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.2 | 7.8 | GO:0030507 | spectrin binding(GO:0030507) |
0.2 | 0.6 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.2 | 0.8 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 0.7 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
0.1 | 1.5 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 1.0 | GO:0016004 | phospholipase activator activity(GO:0016004) lipase activator activity(GO:0060229) |
0.1 | 21.0 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 4.0 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 1.5 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 3.3 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.1 | 1.1 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 2.2 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 3.4 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 1.0 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.1 | 3.9 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.1 | 1.5 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.1 | 0.8 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 2.9 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 2.5 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 0.4 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 1.0 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.1 | 6.4 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.1 | 2.2 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.1 | 11.2 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.1 | 3.5 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 2.3 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 0.6 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 4.7 | GO:0016278 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.1 | 0.6 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.1 | 1.7 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.1 | 29.8 | GO:0061659 | ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.1 | 1.2 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.1 | 2.2 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.1 | 2.0 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 3.8 | GO:0030276 | clathrin binding(GO:0030276) |
0.1 | 4.6 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.1 | 1.1 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.1 | 1.2 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 2.5 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 4.4 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 2.8 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 3.9 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.1 | 0.2 | GO:0097677 | STAT family protein binding(GO:0097677) |
0.1 | 0.6 | GO:1990430 | G-protein coupled GABA receptor activity(GO:0004965) extracellular matrix protein binding(GO:1990430) |
0.1 | 7.2 | GO:0000149 | SNARE binding(GO:0000149) |
0.1 | 1.3 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 2.2 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 4.8 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.4 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.1 | 1.6 | GO:0008483 | transaminase activity(GO:0008483) |
0.1 | 5.7 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.1 | 1.1 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 0.6 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.1 | 0.9 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 18.3 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.1 | 1.3 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 2.5 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 0.7 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.1 | 3.4 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.1 | 1.1 | GO:0020037 | heme binding(GO:0020037) |
0.1 | 2.1 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.1 | 1.6 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 6.2 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 22.1 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.1 | 1.7 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 0.6 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.1 | 0.3 | GO:0004921 | interleukin-11 receptor activity(GO:0004921) interleukin-11 binding(GO:0019970) |
0.1 | 0.2 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.1 | 8.4 | GO:0005516 | calmodulin binding(GO:0005516) |
0.1 | 2.5 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.1 | 0.7 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.1 | 1.8 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 1.9 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 0.9 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.1 | 1.0 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 0.5 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 0.5 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 3.2 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.1 | 24.5 | GO:0008270 | zinc ion binding(GO:0008270) |
0.1 | 0.6 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.1 | 0.3 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.1 | 1.1 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.0 | 18.7 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 0.6 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.0 | 0.2 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
0.0 | 0.0 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.0 | 1.6 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 1.8 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.0 | 0.2 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.0 | 0.4 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.0 | 2.0 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.0 | 0.5 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.8 | GO:0004407 | histone deacetylase activity(GO:0004407) protein deacetylase activity(GO:0033558) |
0.0 | 0.9 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.0 | 0.4 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.0 | 0.3 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.0 | 0.7 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.0 | 0.9 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.0 | 0.3 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.0 | 0.7 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.2 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.0 | 0.5 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.1 | GO:0017050 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
0.0 | 0.4 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.0 | 0.5 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.0 | 0.2 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.0 | 1.1 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.0 | 1.3 | GO:0043022 | ribosome binding(GO:0043022) |
0.0 | 3.8 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.0 | 11.5 | GO:0005509 | calcium ion binding(GO:0005509) |
0.0 | 16.8 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.0 | 0.1 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
0.0 | 1.0 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.8 | GO:0050660 | flavin adenine dinucleotide binding(GO:0050660) |
0.0 | 0.2 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 0.7 | GO:0004553 | hydrolase activity, hydrolyzing O-glycosyl compounds(GO:0004553) |
0.0 | 0.2 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.1 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.0 | 0.3 | GO:0015605 | organophosphate ester transmembrane transporter activity(GO:0015605) |
0.0 | 1.0 | GO:0016810 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds(GO:0016810) |
0.0 | 0.0 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) coenzyme transporter activity(GO:0051185) |
0.0 | 0.5 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.0 | 0.4 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.3 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.0 | 0.5 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
Gene overrepresentation in C2:CP category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 13.6 | PID_BETA_CATENIN_DEG_PATHWAY | Degradation of beta catenin |
0.5 | 11.2 | ST_G_ALPHA_S_PATHWAY | G alpha s Pathway |
0.4 | 6.2 | PID_TCR_JNK_PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.3 | 11.5 | PID_TCR_CALCIUM_PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.3 | 15.7 | ST_JNK_MAPK_PATHWAY | JNK MAPK Pathway |
0.3 | 1.5 | ST_PAC1_RECEPTOR_PATHWAY | PAC1 Receptor Pathway |
0.3 | 5.0 | PID_HEDGEHOG_GLI_PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.3 | 8.0 | PID_HDAC_CLASSIII_PATHWAY | Signaling events mediated by HDAC Class III |
0.3 | 2.1 | PID_RAC1_PATHWAY | RAC1 signaling pathway |
0.2 | 4.1 | PID_MET_PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.2 | 5.5 | SA_CASPASE_CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.2 | 8.8 | PID_NCADHERIN_PATHWAY | N-cadherin signaling events |
0.2 | 3.5 | SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.2 | 12.2 | PID_HES_HEY_PATHWAY | Notch-mediated HES/HEY network |
0.2 | 17.9 | PID_AR_PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 3.2 | PID_WNT_NONCANONICAL_PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 1.3 | PID_P38_GAMMA_DELTA_PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 3.5 | PID_TOLL_ENDOGENOUS_PATHWAY | Endogenous TLR signaling |
0.1 | 3.1 | ST_P38_MAPK_PATHWAY | p38 MAPK Pathway |
0.1 | 1.8 | PID_LPA4_PATHWAY | LPA4-mediated signaling events |
0.1 | 2.4 | PID_NECTIN_PATHWAY | Nectin adhesion pathway |
0.1 | 0.2 | PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.1 | 6.8 | PID_INSULIN_PATHWAY | Insulin Pathway |
0.1 | 4.2 | PID_RHOA_PATHWAY | RhoA signaling pathway |
0.1 | 2.5 | PID_ARF_3PATHWAY | Arf1 pathway |
0.1 | 3.2 | PID_TNF_PATHWAY | TNF receptor signaling pathway |
0.1 | 3.1 | PID_VEGFR1_2_PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.1 | 4.8 | PID_TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 0.5 | PID_HIF1A_PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 2.4 | PID_RAS_PATHWAY | Regulation of Ras family activation |
0.1 | 2.9 | PID_ATM_PATHWAY | ATM pathway |
0.1 | 1.6 | PID_CXCR3_PATHWAY | CXCR3-mediated signaling events |
0.1 | 1.5 | PID_NFAT_TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 1.1 | PID_ANGIOPOIETIN_RECEPTOR_PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 2.6 | PID_TCPTP_PATHWAY | Signaling events mediated by TCPTP |
0.1 | 12.3 | NABA_SECRETED_FACTORS | Genes encoding secreted soluble factors |
0.1 | 0.5 | ST_GRANULE_CELL_SURVIVAL_PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 1.5 | PID_CDC42_PATHWAY | CDC42 signaling events |
0.1 | 0.8 | PID_IL12_STAT4_PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 2.4 | PID_REG_GR_PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 1.6 | PID_ECADHERIN_NASCENT_AJ_PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 0.5 | PID_INTEGRIN_A4B1_PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 1.4 | PID_INTEGRIN3_PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 1.3 | PID_PDGFRB_PATHWAY | PDGFR-beta signaling pathway |
0.0 | 1.8 | PID_LKB1_PATHWAY | LKB1 signaling events |
0.0 | 1.6 | PID_AVB3_INTEGRIN_PATHWAY | Integrins in angiogenesis |
0.0 | 1.1 | PID_FANCONI_PATHWAY | Fanconi anemia pathway |
0.0 | 0.8 | PID_IL4_2PATHWAY | IL4-mediated signaling events |
0.0 | 0.3 | ST_ERK1_ERK2_MAPK_PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 0.5 | PID_FGF_PATHWAY | FGF signaling pathway |
0.0 | 2.1 | PID_P53_DOWNSTREAM_PATHWAY | Direct p53 effectors |
0.0 | 0.8 | PID_P53_REGULATION_PATHWAY | p53 pathway |
0.0 | 0.2 | SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.3 | PID_TRKR_PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.3 | PID_EPHB_FWD_PATHWAY | EPHB forward signaling |
0.0 | 0.1 | PID_S1P_META_PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
Gene overrepresentation in C2:CP:REACTOME category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 0.7 | REACTOME_THROMBOXANE_SIGNALLING_THROUGH_TP_RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.6 | 11.7 | REACTOME_CTNNB1_PHOSPHORYLATION_CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.6 | 13.6 | REACTOME_INSULIN_SYNTHESIS_AND_PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.5 | 14.0 | REACTOME_CIRCADIAN_REPRESSION_OF_EXPRESSION_BY_REV_ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.4 | 9.8 | REACTOME_BRANCHED_CHAIN_AMINO_ACID_CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.4 | 3.5 | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION_IN_TLR7_8_OR_9_SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.4 | 3.5 | REACTOME_IRAK2_MEDIATED_ACTIVATION_OF_TAK1_COMPLEX_UPON_TLR7_8_OR_9_STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.4 | 17.9 | REACTOME_CIRCADIAN_CLOCK | Genes involved in Circadian Clock |
0.4 | 5.1 | REACTOME_REGULATION_OF_RHEB_GTPASE_ACTIVITY_BY_AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.4 | 10.7 | REACTOME_PRE_NOTCH_TRANSCRIPTION_AND_TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.4 | 18.7 | REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_RAS | Genes involved in CREB phosphorylation through the activation of Ras |
0.3 | 5.6 | REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.3 | 4.2 | REACTOME_NEF_MEDIATED_DOWNREGULATION_OF_MHC_CLASS_I_COMPLEX_CELL_SURFACE_EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.3 | 10.1 | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.3 | 9.8 | REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS | Genes involved in Voltage gated Potassium channels |
0.2 | 2.6 | REACTOME_REGULATION_OF_HYPOXIA_INDUCIBLE_FACTOR_HIF_BY_OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.2 | 3.3 | REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.2 | 9.6 | REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.2 | 0.9 | REACTOME_DESTABILIZATION_OF_MRNA_BY_TRISTETRAPROLIN_TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.2 | 5.8 | REACTOME_MYOGENESIS | Genes involved in Myogenesis |
0.2 | 7.2 | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.2 | 9.9 | REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.2 | 3.9 | REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.2 | 2.0 | REACTOME_PROTEOLYTIC_CLEAVAGE_OF_SNARE_COMPLEX_PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.2 | 14.2 | REACTOME_MEIOTIC_SYNAPSIS | Genes involved in Meiotic Synapsis |
0.2 | 1.5 | REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.2 | 4.2 | REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.2 | 3.5 | REACTOME_SIGNALING_BY_HIPPO | Genes involved in Signaling by Hippo |
0.2 | 3.5 | REACTOME_NEPHRIN_INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 7.5 | REACTOME_RNA_POL_III_TRANSCRIPTION | Genes involved in RNA Polymerase III Transcription |
0.2 | 1.2 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_EARLY_ENDOSOME_MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.2 | 5.2 | REACTOME_SIGNALING_BY_FGFR1_FUSION_MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 2.5 | REACTOME_MRNA_DECAY_BY_5_TO_3_EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 1.6 | REACTOME_REGULATION_OF_IFNG_SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 2.6 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 2.0 | REACTOME_DEADENYLATION_OF_MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 5.5 | REACTOME_PIP3_ACTIVATES_AKT_SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.1 | 3.9 | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.1 | 1.8 | REACTOME_ACYL_CHAIN_REMODELLING_OF_PC | Genes involved in Acyl chain remodelling of PC |
0.1 | 3.6 | REACTOME_PEROXISOMAL_LIPID_METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 3.6 | REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 2.0 | REACTOME_REGULATION_OF_SIGNALING_BY_CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 1.6 | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 3.3 | REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.1 | 4.3 | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 3.3 | REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 3.6 | REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
0.1 | 1.7 | REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.1 | 1.4 | REACTOME_MTORC1_MEDIATED_SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.1 | 3.3 | REACTOME_SIGNALING_BY_ROBO_RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 3.1 | REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 1.9 | REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
0.1 | 1.5 | REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 2.2 | REACTOME_SYNTHESIS_OF_PA | Genes involved in Synthesis of PA |
0.1 | 2.0 | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 1.7 | REACTOME_AMYLOIDS | Genes involved in Amyloids |
0.1 | 0.7 | REACTOME_COPI_MEDIATED_TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 1.9 | REACTOME_DARPP_32_EVENTS | Genes involved in DARPP-32 events |
0.1 | 1.4 | REACTOME_N_GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIAL_TRANS_GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.1 | 1.2 | REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 0.3 | REACTOME_THE_NLRP3_INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.1 | 1.3 | REACTOME_GLUTATHIONE_CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.6 | REACTOME_MEIOTIC_RECOMBINATION | Genes involved in Meiotic Recombination |
0.0 | 0.6 | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.1 | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 0.3 | REACTOME_GLUCOSE_TRANSPORT | Genes involved in Glucose transport |
0.0 | 0.7 | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.0 | 0.7 | REACTOME_FANCONI_ANEMIA_PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.4 | REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.0 | 1.2 | REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.0 | 0.7 | REACTOME_EGFR_DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 1.1 | REACTOME_GLYCOSPHINGOLIPID_METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.5 | REACTOME_GAP_JUNCTION_DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.9 | REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.3 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 0.2 | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_ACTIVITY_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |